PARTNERSHIPS FOR NOVEL THERAPEUTIC, DIAGNOSTIC AND VECTOR CONTROL STRATEGIES IN INFECTIOUS DISEASES ADDENDUM TO PAR-02-026 Release Date: April 10, 2002 NOTICE: NOT-AI-02-013 (also see PAR-02-026, NOT-AI-02-22, NOT-AI-02-007) National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov/default.htm) Letter of Intent Receipt Date: May 20, 2002 Application Receipt Date: June 20, 2002 The National Institute of Allergy and Infectious Diseases is removing language as well as stating the letter of intent receipt date previously omitted. The NIAID would also like to announce that additional initiatives relating to the areas of Bio-Defense and Influenza will soon be published in the "NIH Guide". The Letter of Intent receipt date for the second receipt date is May 20, 2002. The Application receipt date had been changed to June 20, 2002, as announced in NOT-AI-02-007 at http://grants.nih.gov/grants/guide/notice- files/NOT-AI-02-007.html Under Research Objectives and Scope, area #4 will be removed and addressed in upcoming initiatives: #4. Development of Vaccines for Selected Agents of Bioterrorism: Responsive applications to scientific area "4." include those that propose to develop vaccines to prevent infection and/or disease from CDC Category A agents of bioterrorism (B. anthracis, Clostridium botulinum. Yersinia pestis, Variola major, Francisella tularensis and causative pathogens of viral hemorrhagic fevers). Proposed research may fall anywhere along a broad spectrum of activities from candidate identification and validation through preclinical development and early human testing (Phase I and II trials). Also note that applications relating to Influenza will also not be accepted under this PAR. An announcement coming out in the next few months will apply to both the above areas. Complete information about the grant program, PAR-02-026, may be obtained at http://www.niaid.nih.gov/ncn/pa/PAR-02-026.html. INQUIRIES Written and telephone inquiries are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic, research scope, and eligibility issues to: Ann M. Ginsberg, M.D., Ph.D. Division of Microbiology and Infectious Diseases National Institute of Allergy and Infectious Diseases Room 3133, MSC-7630 6700-B Rockledge Drive Bethesda, MD 20892-7630 Telephone: (301) 496-5305 FAX: (301) 496-8030 E-Mail: ag73i@nih.gov Direct inquiries regarding fiscal matters to: Ms. Jeanette Gordon Division of Extramural Activities National Institute of Allergy and Infectious Diseases Room 3222, MSC-7614 6700-B Rockledge Drive Bethesda, MD 20892-7614 Telephone: (301) 402-5065 Fax: (301) 480-3780 E-mail: jgordon@niaid.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.